Quick Numbers
| Review timing | Month 6 and month 12 |
|---|---|
| Early shedding | Weeks 2-8 common |
| Donor reassess | 10-12 months |
| Planning focus | Reserve plus realism |
Key Takeaways
| Long-term results depend on donor reserve and native hair stability. |
| Temporary shedding phases are common and not always graft failure. |
| Photo documentation improves decision quality at follow-up. |
| Medical therapy may protect non-transplanted hair when indicated. |
Quick Numbers
| Normal shed | ~50–100/day |
|---|---|
| Scalp hairs | ~100,000 total |
| See doctor if | >2 months excess |
| Growth cycle | Anagen / telogen |
Key Takeaways
| Shedding is normal until it exceeds your baseline. |
| Diagnosis first, thyroid, iron, hormones matter. |
| Genetic loss needs long-term plan, not shampoo alone. |
| Transplant fits stable pattern loss with good donor. |
Hair loss scares patients because every shower drain looks like an emergency. Healthy scalps renew constantly, old hairs exit so new ones can grow. Problems start when shedding outpaces regrowth for months or when visible scalp appears in mirror light. Separating normal turnover from disease guides whether you need labs, medication, or transplant planning.
Normal Shedding vs Problem Thinning
Each follicle cycles through growth and rest phases. Losing near one hundred hairs daily can be normal on a scalp carrying roughly one hundred thousand total. Seasonal sheds, postpartum shifts, and recovery after fever can temporarily increase counts without permanent baldness.
Persistent shedding beyond about two months, widening part lines, or temple recession warrants evaluation. Do not transplant active unexplained shedding without workup. You may waste grafts on follicles that would recover medically.
Common Causes to Test
| Phase | Focus |
|---|---|
| Weeks 0-2 | Protection and washing protocol |
| Weeks 2-8 | Monitor temporary shedding |
| Months 3-6 | Early regrowth assessment |
| Months 10-12 | Plan next steps if needed |
Nutrition matters when deficiency exists, but supplements alone rarely reverse genetic thinning. Discuss PRP and mesotherapy with a clinician who has seen your labs, not a social media stack of vitamins.
A structured mesotherapy set can form part of a clinic-supervised scalp care plan when prescribed alongside PRP.
Dr. Caymaz Insight
| I tell patients to judge progress on timeline and standardized photos, not daily mirror checks during the first recovery months. |
Treatment Paths: Medical to Surgical
Stabilize loss before cosmetic redistribution. Medications, PRP, and lifestyle changes may slow progression. When pattern is stable and donor is adequate, surgery moves permanent follicles to visible zones. Read transplant candidacy and medication options as complementary paths, not rivals.
Women with diffuse part widening follow Ludwig patterns. See women’s planning. Men with temple recession map against Norwood staging in graft planning.
Next Step: Document and Consult
Track shed counts for two weeks, note medications and stress events, and photograph top and front views monthly. Submit through consultation so recommendations match your cause, not generic shampoo advice.
When Hair Loss Is Reversible
Telogen effluvium after surgery, illness, or crash dieting often self-corrects over six to nine months once the trigger stops. Traction alopecia improves when tight styles end early enough. Scarring alopecia needs dermatology first, transplant into active inflammation fails. For visiting patients, hair loss treatment in Turkey follows the same sequence: diagnosis before any procedure.
Building a Long-Term Plan
Genetic thinning usually needs ongoing strategy: medical stabilization, optional regenerative sessions, then surgical redistribution when the pattern is predictable. Jumping straight to grafts without stabilizing rapid shed wastes donor, a finite resource. Review planning timelines with a clinician who tracks your photos over time.
Sources & clinical references
FAQ
Roughly 50–100 hairs per day on a healthy scalp; more with seasonal sheds or after illness.
If increased shedding lasts beyond about two months or you see visible thinning patches.
Yes, telogen effluvium after major stress or illness often improves when the trigger resolves.
They help only when a documented deficiency exists; they do not reverse genetic pattern loss alone.
When loss pattern is stable, donor is adequate, and medical causes are addressed or ruled out.
Workup overlaps, but pattern types differ. Ludwig vs Norwood guides next steps.
Hair Loss — Frequently Asked Questions
Expert Answers by Dr. Erkam Caymaz, Istanbul
In men, about 95% of cases come down to androgenetic alopecia — genetic sensitivity to DHT (dihydrotestosterone). Other causes include stress-related telogen effluvium, autoimmune alopecia areata, thyroid imbalance, iron deficiency, post-pregnancy shedding, and certain medications. Dr. Erkam Caymaz diagnoses the exact pattern at consultation before recommending any treatment.
Finasteride blocks the enzyme 5-alpha-reductase, reducing scalp DHT and slowing miniaturisation of follicles. Minoxidil is a topical vasodilator that lengthens the anagen (growth) phase and improves perfusion. Both are evidence-based and complementary. Mechanism detail: Minoxidil and Finasteride Mechanism.
For early to moderate androgenetic loss — yes, often. A combination of finasteride, minoxidil, mesotherapy, and lifestyle adjustments can stabilise loss and partially recover density. Transplantation enters the picture only when miniaturisation has progressed past medical reversal. See: Ways to Stop Hair Loss.
Female pattern hair loss typically shows as diffuse thinning over the crown with a preserved frontal hairline, rather than the receding pattern seen in men. Hormonal factors, post-partum periods, iron, thyroid, and PCOS all play larger roles. We tailor every diagnostic workup and our female hair transplant protocol around these specifics.
When loss has reached Norwood 3 or higher in men (or a clearly visible thinning pattern in women), when medical therapy alone is no longer reversing the loss, when the donor area is still dense, and when the patient is at least 25-26 years old with a stable pattern. Dr. Caymaz reviews all these factors before clearing surgery — patient suitability is decided clinically, not commercially.
